UK markets closed

LH Jan 2023 260.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
20.000.00 (0.00%)
As of 02:08PM EDT. Market open.
Full screen
Previous close20.00
Expiry date2023-01-20
Day's range20.00 - 20.00
Contract rangeN/A
Open interest93
  • Zacks

    LabCorp (LH) Introduces Latest Assay for Skin Cancer Patients

    LabCorp's (LH) new assay is claimed to have shown a demonstrable clinical advantage in patients suffering from melanoma.

  • Business Wire

    Labcorp Launches New Test for People With Skin Cancer

    BURLINGTON, N.C., May 18, 2022--Finding treatment options for skin cancer may become easier with the launch of a new test by Labcorp (NYSE: LH), a leading global life sciences company. The new test measures Lymphocyte-activation gene 3 (LAG-3) expression levels by immunohistochemistry (IHC) in tumor tissue. LAG-3 is an immune-oncology target with demonstrable clinical benefit in patients with melanoma. The test is available for use in both clinical trials and for the care and treatment of patien

  • Business Wire

    Labcorp Receives Emergency Use Authorization for First Non-Prescription At-Home Collection Kit for Combined COVID-19, Flu and RSV Detection

    BURLINGTON, N.C., May 18, 2022--Labcorp (NYSE: LH), a leading global life sciences company, today announced the receipt of Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined at-home collection kit available that simultaneously detects COVID-19, influenza A/B and respiratory syncytial virus (RSV), a common but contagious respiratory virus often seen in children.